Recent studies revealed that patientsvaccinatedwithGP2+GM-CSF showed a 37% reduction in cancer recurrence compared to unvaccinated patients while those who received GM-CSF alone showed57% reduction in risk of cancer recurrence [40]. The gene discussed is CSF2; the disease is cancer.